Author

Cody L. Wolf

University of VirginiaORCID 0000-0002-4769-9571Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Amanda PoissonnieriD· 1 shared Edward B. StelowiD· 1 shared Karl M. Kowalewski· 1 shared Kimberly A. KellyiD· 1 shared Lisa M. CoussensiD· 1 shared Matthew J. LazzaraiD· 1 shared Robert CornelisoniD· 1 shared Roxanne K. Ruiz· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amanda PoissonnierORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Plectin promotes an aggressive phenotype and represses cytotoxic T cell activity in pancreatic cancer

Cody L. Wolf, Roxanne K. Ruiz, Sokchea Khou, Robert Cornelison, Edward B. Stelow, Karl M. Kowalewski, Matthew J. Lazzara, Amanda Poissonnier, Lisa M. Coussens, Kimberly A. Kelly

This study identifies plectin as a biomarker of aggressive pancreatic cancer, showing it suppresses T cell activity and that targeting it with an antibody enhances anti-tumor immunity.

Frontiers in Immunology · Aug 17, 2026Peer-reviewedCancer Biology